Press release
Primary Catalyst Driving mRNA Cancer Vaccines And Therapeutics Market Evolution in 2025: Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth Driver
mRNA Cancer Vaccines And Therapeutics Market Size
In recent times, there has been a significant expansion in the market size of mRNA cancer vaccines and therapeutics. From a worth of $61.52 billion in 2024, it's projected to escalate to $71.85 billion in 2025, marking a 16.8% compound annual growth rate (CAGR). The growth during the historical period can be traced back to a combination of factors such as lifestyle changes, access to funding, favorable regulatory conditions, a robust healthcare infrastructure, and a rise in pipeline development.
Over the next few years, a swift expansion is anticipated in the market size of mRNA cancer vaccines and therapeutics, projecting a rise to $131.99 billion by 2029, with a compound annual growth rate (CAGR) of 16.4%. This surge within the prediction timeframe is credited to several factors such as encouraging outcomes from clinical trials, an increase in understanding and acceptance of mRNA technology, unfulfilled demands in cancer care, possibilities for better patient results, and potential for constant availability off-the-shelf. Significant trends for the forecast duration include branching into novel therapeutic fields, emphasis on personalized medical solutions, breakthroughs in mRNA delivery mechanisms, multivalent mRNA vaccines, and the application of artificial intelligence and machine learning in mRNA blueprint development.
What Are the Forces Behind the Rapid Growth of the mRNA Cancer Vaccines And Therapeutics Market?
The increase in cancer prevalence is projected to boost the expansion of the mRNA cancer vaccine and therapeutics market. Cancer, a collective term encompassing a variety of diseases hallmarked by the unregulated expansion and dispersion of abnormal cells resulting in destruction of healthy body tissue, is on the rise due to sedentary lifestyles, unhealthy dietary patterns and exposure to environmental toxins. mRNA cancer vaccines and therapeutics are considered essential in cancer management due to their ability to provide customized, targeted treatments that fortify the immune system's capacity to detect and combat cancer cells, thereby amplifying the effectiveness of treatment and patient prognosis. For example, statistics from the American Cancer Society, a non-profit organization in the US dedicated to combating cancer, indicates that in January 2023, the number of new cancer cases in the US ascended from around 1,918,030 in 2022 to 1,958,310 in 2023. Breast cancer remains the prevalent chronic condition in the US, climbing from 287,850 cases in 2022 to 297,790 cases in 2023. Consequently, the surge in cancer prevalence is a key driver in the growth of the mRNA cancer vaccine and therapeutics market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17204&type=smp
Which Key Market Leaders Are Driving mRNA Cancer Vaccines And Therapeutics Industry Growth?
Major companies operating in the mRNA cancer vaccines and therapeutics market are Pfizer Inc., Merck & Co Inc., Bayer AG, Novartis SA, Sanofi AG, AstraZeneca Plc, GlaxoSmithKline Plc, Hoffmann-La Roche AG, Eli Lilly and Company, Moderna Therapeutics Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Catalent Inc., Sarepta Therapeutics Inc., Arcturus Therapeutics Holdings Inc., Genentech Inc., Immatics Biotechnologies GmbH, CureVac N.V, Anima Biotech, Argos Therapeutics Inc.
What Are the Emerging Trends in the mRNA Cancer Vaccines And Therapeutics Industry?
Major companies in the mRNA cancer vaccines and therapeutics market are concentrating their efforts on creating innovative treatments like mRNA cancer vaccines to increase effectiveness, enhance patient outcomes, and satisfy the increasing need for powerful cancer treatments. mRNA cancer vaccines, a variety of immunotherapy, use messenger RNA to tell cells to produce specific antigens, subsequently triggering the immune system to identify and combat cancer cells. To illustrate, in May 2024, the biotechnology firm based in China, WestGene Biopharma, gained FDA approval for a new investigational drug application, an mRNA therapeutic cancer vaccine named WGc-043. This FDA approval signifies a significant advancement in the treatment of advanced EB virus-related cancers, which have strong associations with over ten types of cancer, including nasopharyngeal carcinoma, NK T-cell lymphoma, as well as gastric, lung, liver, esophageal, breast, and cervical cancers, and also autoimmune diseases like multiple sclerosis and lupus.
What Are the Main Segments in the mRNA Cancer Vaccines And Therapeutics Market?
The mRNA cancer vaccines and therapeutics market covered in this report is segmented -
1) By Type: Adeno Carcinomas, Mucinous Carcinomas, Adenosquamous Carcinomas
2) By Application: Infectious Disease, Cancer, Other Applications
3) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Research Institutes, Other End Users
Subsegments:
1) By Adeno Carcinomas: Lung Adenocarcinomas, Colon Adenocarcinomas, Prostate Adenocarcinomas
2) By Mucinous Carcinomas: Mucinous Ovarian Cancer, Mucinous Breast Cancer, Mucinous Colorectal Cancer
3) By Adenosquamous Carcinomas: Pancreatic Adenosquamous Carcinoma, Cervical Adenosquamous Carcinoma, Esophageal Adenosquamous Carcinoma
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/mrna-cancer-vaccines-and-therapeutics-global-market-report
Which Geographic Area Leads the mRNA Cancer Vaccines And Therapeutics Market?
North America was the largest region in the mRNA cancer vaccination and therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mRNA cancer vaccines and therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The mRNA Cancer Vaccines And Therapeutics Global Market Report?
- Market Size Analysis: Analyze the mRNA Cancer Vaccines And Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the mRNA Cancer Vaccines And Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall mRNA Cancer Vaccines And Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the mRNA Cancer Vaccines And Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17204
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Catalyst Driving mRNA Cancer Vaccines And Therapeutics Market Evolution in 2025: Surge In Cancer Prevalence Boosts mRNA Vaccine And Therapeutics Market Growth Driver here
News-ID: 3864386 • Views: …
More Releases from The Business Research Company
Road Maintenance Market Expected to Achieve 5.7% CAGR by 2029: Growth Forecast I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Road Maintenance Market Size By 2025?
In recent times, there has been a significant increase in the size of the road maintenance market. It's projected to expand from $14.55 billion in 2024 to $15.34 billion in 2025, with a compound annual growth rate (CAGR) of…
Navigating the Future: Aggregate In Road Construction Market Trends and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Aggregate In Road Construction Market Size Growth Forecast: What to Expect by 2025?
The total market size for aggregate in road construction has seen a swift surge in the past few years. It is projected to rise from $828.16 billion in 2024 to reach $928.75 billion in 2025, with…
Technological Advancements In Low-Carbon Construction Materials Industry Trends …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Low Carbon Construction Materials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been a robust growth in the size of the low carbon construction materials market in recent years, expanding from $259.42 billion in 2024 to an expected $281.84 billion in 2025. This…
Impact Of Increasing Construction Activities On The Crane And Hoist Market: Stre …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Crane And Hoist Market Through 2025?
In recent times, there has been a consistent increase in the size of the crane and hoist market. Anticipated growth is from $32.33 billion in 2024 to $33.81 billion in 2025, representing a compound annual growth…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
